[Diabetic nephropathies].
Makino
Hiroshi
H
D000419:Albuminuria; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D015415:Biomarkers / Q000652:urine; D024141:Collagen Type IV / Q000652:urine; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D003956:Dialysis; D042241:Early Diagnosis; D019317:Evidence-Based Medicine; D005919:Glomerular Filtration Rate; D017127:Glycation End Products, Advanced; D006801:Humans; D007249:Inflammation; D007678:Kidney Glomerulus / Q000098:blood supply; D011493:Protein Kinase C
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D024141:Collagen Type IV; D017127:Glycation End Products, Advanced; D011493:Protein Kinase C